Pembrolizumab in Early Stage Colon Cancer

首次发布于 2020 年 1 月 18 日

Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer

计划入组 2,000 人 · 首次发布于 2009 年 8 月 13 日

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

计划入组 2,000 人 · 首次发布于 2011 年 3 月 3 日

colon cancer therapy (NCI)

siRNA agent (colon cancer)

CB-548

SWEET CHEEKS COLON CARE PTY LTD

Australia

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Roche's Tecentriq Cuts Colon Cancer Recurrence by 50% in Patients with DNA Repair Defects

World-First Clinical Trial Demonstrates Exercise Significantly Improves Colon Cancer Survival

DYNAMIC-III Trial Shows Promise for ctDNA-Guided Chemotherapy De-escalation in Stage III Colon Cancer